Strata Skin Sciences today said that it has appointed Robert Moccia as president and CEO, effective immediately.
Moccia replaces former president Dolev Rafaeli, who stepped down as president and CEO on Feb. 28.
“We are delighted to welcome Bob to the Strata team. He is a leader in the field of dermatology, and we are confident that his extensive executive management experience, spanning more than three decades in healthcare, predominantly in the dermatology sector, will deliver a seamless transition,” chairperson Uri Geiger said in a news release. “Looking forward, we believe his proven track record leading and building PE-backed dermatology growth companies, combined with a broad operational skillset, will prove to be an asset as we work towards delivering meaningful value to STRATA’s customers, patients and shareholders.”
Prior to joining the company, Moccia served as president, CEO and cofounder of Encore Dermatology. He has also been CEO of Precision Dermatology. He has also held numerous leadership roles at Graceway Pharmaceuticals, Dermik and Stiefel Laboratories.
“I am confident that Strata has the technology and team in place to be a leader in the treatment of dermatologic conditions,” Moccia said. “I look forward to immediately contributing to the Company’s unique and proven direct-to-consumer business model and working with the great team that has been assembled. I want to extend my gratitude to the board for their confidence in my ability to lead and grow this exciting company.”
